摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,3-二甲氧基-6-甲基-喹喔啉 | 69722-50-5

中文名称
2,3-二甲氧基-6-甲基-喹喔啉
中文别名
——
英文名称
2,3-dimethoxy-6-methyl-quinoxaline
英文别名
2,3-Dimethoxy-6-methyl-chinoxalin;2,3-Dimethoxy-6-methylquinoxaline
2,3-二甲氧基-6-甲基-喹喔啉化学式
CAS
69722-50-5
化学式
C11H12N2O2
mdl
——
分子量
204.228
InChiKey
VLACLKWCHQHLHP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    15
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.27
  • 拓扑面积:
    44.2
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2,3-二甲氧基-6-甲基-喹喔啉N-溴代丁二酰亚胺(NBS)过氧化氢苯甲酰 作用下, 以 四氯化碳 为溶剂, 反应 16.0h, 以76%的产率得到6-溴甲基-2,3-二甲氧基-喹噁啉
    参考文献:
    名称:
    Quinoxaline chemistry Part 9. Quinoxaline analogues of trimetrexate (TMQ) and 10-propargyl-5,8-dideazafolic acid (CB 3717) and its precursors. Synthesis and evaluation of in vitro anticancer activity
    摘要:
    Eighteen quinoxalines bearing a methyleneanilino or methyleneaminobenzoylglutamate group on position 6 of the ring and various lipophilic substituents on positions 2 and 3 were prepared in order to discover if their structural analogy with both trimetrexate (TMQ) and 10-propargyl-5,8-dideazafolic acid (CB 3717) might display in vitro anticancer activity. Among these, 12 compounds were selected at the National Cancer Institute, Bethesda, MD, USA; they exhibited moderate (4b,d,i,l,m and 8) to strong (4f,h and 5a,e) cell-growth inhibition at a concentration of 10(-4) M. Interesting selectivities were also recorded between 10(-8) and 10(-6) M. These analogues proved to be less potent inihibitors of tumor cells than other classical and non-classical antifolate analogues previously described by us. (C) 1998 Elsevier Science S.A. All rights reserved.
    DOI:
    10.1016/s0014-827x(98)00002-0
  • 作为产物:
    参考文献:
    名称:
    275.合成抗疟药。第XL部分。2-氯-3 - β-二乙基氨基乙基氨基喹喔啉中取代基变化的影响
    摘要:
    DOI:
    10.1039/jr9490001271
点击查看最新优质反应信息

文献信息

  • US4184977A
    申请人:——
    公开号:US4184977A
    公开(公告)日:1980-01-22
  • USRE30352E
    申请人:——
    公开号:USRE30352E
    公开(公告)日:1980-07-29
  • [EN] INHIBITORS OF ALPHA-HEMOLYSIN OF STAPHYLOCOCCUS AUREUS<br/>[FR] INHIBITEURS DE L'ALPHA-HÉMOLYSINE DE STAPHYLOCOCCUS AUREUS
    申请人:[en]HELMHOLTZ-ZENTRUM FÜR INFEKTIONSFORSCHUNG GMBH
    公开号:WO2023280970A1
    公开(公告)日:2023-01-12
    The present invention relates to novel inhibitors of α-hemolysin of formula (I) and the use thereof for the prophylaxis and treatment of infections caused byStaphylococcusaureus; especiallyS. aureuslung infections.
  • 275. Synthetic antimalarials. Part XL. The effect of variation of substituents in 2-chloro-3-β-diethylaminoethylaminoquinoxaline
    作者:F. H. S. Curd、D. G. Davey、G. J. Stacey
    DOI:10.1039/jr9490001271
    日期:——
  • Quinoxaline chemistry Part 9. Quinoxaline analogues of trimetrexate (TMQ) and 10-propargyl-5,8-dideazafolic acid (CB 3717) and its precursors. Synthesis and evaluation of in vitro anticancer activity
    作者:Mario Loriga、Gabriella Vitale、Giuseppe Paglietti
    DOI:10.1016/s0014-827x(98)00002-0
    日期:1998.2
    Eighteen quinoxalines bearing a methyleneanilino or methyleneaminobenzoylglutamate group on position 6 of the ring and various lipophilic substituents on positions 2 and 3 were prepared in order to discover if their structural analogy with both trimetrexate (TMQ) and 10-propargyl-5,8-dideazafolic acid (CB 3717) might display in vitro anticancer activity. Among these, 12 compounds were selected at the National Cancer Institute, Bethesda, MD, USA; they exhibited moderate (4b,d,i,l,m and 8) to strong (4f,h and 5a,e) cell-growth inhibition at a concentration of 10(-4) M. Interesting selectivities were also recorded between 10(-8) and 10(-6) M. These analogues proved to be less potent inihibitors of tumor cells than other classical and non-classical antifolate analogues previously described by us. (C) 1998 Elsevier Science S.A. All rights reserved.
查看更多